Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Alberts

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Contemporary Clinical Trials|July 11, 2016
A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) StudyCynthia A Thomson, Tracy E Crane, Austin Miller, et al.
Analytical and Quantitative Cytology and Histology|June 29, 2004
Karyometric analysis of actinic damage in unexposed and sun-exposed skin and in actinic keratoses in untreated individualsJames Ranger-Moore, Peter H Bartels, Paul Bozzo, et al.
The Journal of Laboratory and Clinical Medicine|July 25, 2003
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survivalJennifer Raffel, Achyut K Bhattacharyya, Alfred Gallegos, et al.
Gastroenterology|November 8, 2006
Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathwayMaría Elena Martínez, Patricia Thompson, Elizabeth T Jacobs, et al.
Pharmacoeconomics|June 28, 2018
Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic CancerMahdi Gharaibeh, Ali McBride, David S Alberts, et al.
Gynecologic Oncology|August 2, 2003
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignanciesMichael A Gold, Joan L Walker, Jonathan S Berek, et al.
Pharmacoeconomics|July 8, 2018
Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic CancerMahdi Gharaibeh, Ali McBride, David S Alberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progressionMary C Clouser, Robin B Harris, Denise J Roe, et al.
Carcinogenesis|August 11, 2007
Meat intake, preparation methods, mutagens and colorectal adenoma recurrenceMaría Elena Martínez, Elizabeth T Jacobs, Erin L Ashbeck, et al.
Analytical and Quantitative Cytology and Histology|January 24, 2009
Actinic damage in histopathologically normal skinPeter H Bartels, Robert S Krouse, Anil R Prasad, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Contemporary Clinical Trials|July 11, 2016
A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) StudyCynthia A Thomson, Tracy E Crane, Austin Miller, et al.
Analytical and Quantitative Cytology and Histology|June 29, 2004
Karyometric analysis of actinic damage in unexposed and sun-exposed skin and in actinic keratoses in untreated individualsJames Ranger-Moore, Peter H Bartels, Paul Bozzo, et al.
The Journal of Laboratory and Clinical Medicine|July 25, 2003
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survivalJennifer Raffel, Achyut K Bhattacharyya, Alfred Gallegos, et al.
Gastroenterology|November 8, 2006
Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathwayMaría Elena Martínez, Patricia Thompson, Elizabeth T Jacobs, et al.
Pharmacoeconomics|June 28, 2018
Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic CancerMahdi Gharaibeh, Ali McBride, David S Alberts, et al.
Gynecologic Oncology|August 2, 2003
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignanciesMichael A Gold, Joan L Walker, Jonathan S Berek, et al.
Pharmacoeconomics|July 8, 2018
Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic CancerMahdi Gharaibeh, Ali McBride, David S Alberts, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progressionMary C Clouser, Robin B Harris, Denise J Roe, et al.
Carcinogenesis|August 11, 2007
Meat intake, preparation methods, mutagens and colorectal adenoma recurrenceMaría Elena Martínez, Elizabeth T Jacobs, Erin L Ashbeck, et al.
Analytical and Quantitative Cytology and Histology|January 24, 2009
Actinic damage in histopathologically normal skinPeter H Bartels, Robert S Krouse, Anil R Prasad, et al.
Pageof 19